Separately, breast cancer stem cells, identified prospectively as tumor initiating cells when transplanted into immunodeficient mice, have been characterized by the surface expression phenotype CD44+/CD24−/low[40], also a presumed phenotype of normal breast epithelial stem or early progenitor cells [84]. This evidence concerns the gene CD44 and breast cancer.